The effect of tofacitinib on residual pain in patients with rheumatoid arthritis and psoriatic arthritis
<p><strong>Objective:</strong> Post hoc analysis of pooled data from 9 randomised controlled trials to assess the effect of tofacitinib (oral Janus kinase inhibitor for treatment of rheumatoid arthritis [RA] and psoriatic arthritis [PsA]) on residual pain in patients with RA or PsA...
প্রধান লেখক: | , , , , , , , |
---|---|
বিন্যাস: | Journal article |
ভাষা: | English |
প্রকাশিত: |
BMJ Publishing Group
2022
|